Analysis published 08 Jun 2026

AI-generated · cited to primary sources · not investment advice

Quick Heal Tech (539678) Aug 2025 Filing Analysis

01 · Management Credibility

Does management do what it says?

MetIndia DPDP Act Driving Privacy Software Demand
85/100

The company confirmed the receipt of its first order for Seqrite Data Privacy during the period. (2 met across 2 tracked commitments)

And like I said, some of the organizations who are forward looking are not waiting for the act to come in. And we are already doing multiple POCs and proposals are there, hopefully we will be able to close more deals this quarter as well.

Quick Heal Tech · Concall Transcript · Aug 2025 · p.9
In progressIndia SaaS Market Approaching USD 100B by 2035
60/100

The company has updated its SOM trajectory, showing a progression from INR 1,100 Cr in FY23 to a projected INR 3,000 Cr in FY25 and INR 3,500 Cr in FY26, remaining on track for the FY27 target. (1 in progress across 1 tracked commitment)

Evolution of Serviceable Operatable Market ... FY 27 4000 Cr

Quick Heal Tech · Investor PPT · Aug 2025 · p.15
Product-Led Growth vs Sales-Led Motion

The company is using a freemium model for the new Anti Fraud.AI product to accelerate consumer adoption.

One of the highlights for this quarter is the launch of Anti Fraud.AI freemium. Introducing a freemium model lets us accelerate adoption among consumers by lowering the barriers.

Quick Heal Tech · Concall Transcript · Aug 2025 · p.2

See the full cited Management analysis of Quick Heal Tech

Create free account →
02 · Business Model

How durable is the business?

Multi-Product Platform Strategy
80/100

The Enterprise segment has reached revenue parity with the Consumer segment, now contributing 50% of total revenue. While gross revenue for the quarter (₹31.7 Cr) showed a slight YoY decline of 2.3%, the segment's share of the total business has expanded significantly from 40% in FY25. (4 expanding)

Deconstructing Current Business... FY 2025: 40% Enterprise; Q1 FY 2026: 50% Enterprise

Quick Heal Tech · Investor PPT · Aug 2025 · p.22
Subscription Revenue Model Maturity
76/100

The enterprise segment faced headwinds with flattish year-on-year results due to deferred deal closures, though the order book remains healthy at Rs. 24 crores. (1 stable, 4 expanding)

In the enterprise segment, we have seen deferral in few deal closures, resulting in a flattish year-on-year result.

Quick Heal Tech · Concall Transcript · Aug 2025 · p.4
AI-Native Product Rewrite Cycle
73/100

The company is evolving its technology moat by integrating AI-driven threat detection (GoDeep.AI) and launching an AI-powered assistant (SIA) for enterprise security. (3 expanding, 1 shifted)

This vision comes to light through cutting edge platforms like GoDeep.AI, an AI driven threat detection... Most recently, we have introduced SIA, Seqrite Intelligent Assistant as a part of our XDR.

Quick Heal Tech · Concall Transcript · Aug 2025 · p.3
India Pricing and Global Pricing Arbitrage
65/100

While India remains the primary market, the company is seeing explosive growth in international revenue, which doubled year-over-year, indicating a strategic push to diversify beyond domestic borders. (1 expanding, 1 shifted)

~2X Growth in International Revenue YoY

Quick Heal Tech · Investor PPT · Aug 2025 · p.21
Product-Led Growth vs Sales-Led Motion
30/100

The consumer segment continues to contract significantly, driving a total revenue decline to Rs. 57 crores from Rs. 70 crores in the previous year's quarter. (1 contracting)

We see revenue declining to Rs.57 crores in Q1 FY’26 compared to Rs.70 crore and Rs.65 crore in Q1 and Q4 of previous year respectively. This dip largely is a result of softer market conditions in the consumer segment.

Quick Heal Tech · Concall Transcript · Aug 2025 · p.4

See the full cited Business Model analysis of Quick Heal Tech

Create free account →
04 · Risk

What could break the thesis?

Product-Led Growth vs Sales-Led Motion

The consumer segment continues to face 'softer market conditions,' with total revenue declining to Rs. 57 crores from Rs. 70 crores in the same quarter last year. This represents a continued downward trend in the core business. (1 intensifying, 1 easing)

We see revenue declining to Rs.57 crores in Q1 FY’26 compared to Rs.70 crore and Rs.65 crore in Q1 and Q4 of previous year respectively. This dip largely is a result of softer market conditions in the consumer segment.

Quick Heal Tech · Concall Transcript · Aug 2025 · p.4

See the full cited Risk analysis of Quick Heal Tech

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.